The contribution of Vitamin D on the Rehabilitation of patients with Chronic Spinal Cord Injury. Newer Data
Keywords:
Spinal Cord injury (SCI), chronic SCI, Vitamin D, 25(OH)Vit D, SCI RehabilitationAbstract
The metabolism and actions of vitamin D in human body are nowadays under intensive investigation. Even if a lot are known about its role in the general population, a few are acquainted as for vitamin’s D effects on people who have sustained a spinal cord injury (SCI). Low mobility, poor nutritional supply and the accompanied coherences of SCI individuals makes them predominant for vitamin D deficiency in comparison to able-bodied people. The so far available studies suggest that the decreased vitamin’s D status probably have a negative action mainly on musculoskeletal system but also on cardiovascular, respiratory and endocrine system, leading to difficulties on patients attempt for rehabilitation and return to everyday activities.
Downloads
References
Bikle DD. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chem Biol. 2014; 21(3): 319-29.
Lamarche J, Mailhot G. Vitamin D and spinal cord injury: should we care?. Spinal Cord 2016; 54(12): 1060–75.
McKinley WO, Gittler MS, Kirshblum SC et al. Spinal cord injury medicine. 2. Medical complications after spinal cord injury: Identification and management. Arch Phys Med Rehabil 2002; 83(3 Suppl 1): 58-64, 90-98.
Hagen EM, Rekand T, Grønning M et al. Cardiovascular complications of spinal cord injury. Tidsskr Nor Laegeforen 2012; 132(9): 1115-20.
Phillips WT, Kiratli BJ, Sarkarati M et al. Effect of spinal cord injury on the heart and cardiovascular fitness. Curr Probl Cardiol 1998; 23(11): 641-16.
Hagen EM, Faerestrand S, Hoff JM et al. Cardiovascular and urological dysfunction in spinal cord injury. Acta Neurol Scand Suppl 2011; (191): 71-8.
Jiang SD, Dai LY, Jiang LS. Osteoporosis after spinal cord injury. Osteoporos Int 2006;17(2): 180-92.
Morse LR, Batagglino RA, Stolzmann KL et al. Osteoporotic fractures and hospitalization risk in chronic spinal cord injury. Osteoporos Int 2009; 20(3): 385-92.
Duckworth WC, Jallepalli P, Solomon SS. Glucose intolerance in spinal cord injury. Arch Phys Med Rehabil 1983; 64(3): 107-10.
Vichiansiri R, Saengsuwan J, Manimmanakorn N et al. The prevalence of dyslipidemia in patients with spinal cord lesion in Thailand. Cholesterol 2012; 2012: 847462.
Norman AW, Frankel JB, Heldt AM et al. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209(4458): 823-25.
Flueck JL, Perret C. Vitamin D deficiency in individuals with a spinal cord injury: a literature review. Spinal Cord 2017; 55(5): 428-34.
Nemunaitis GA, Mejia M, Nagy JA et al. A descriptive study on vitamin D levels in individuals with spinal cord injury in an acute inpatient rehabilitation setting. PM R 2010; 2(3): 202-8.
Flueck JL, Schlaepfer MW, Perret C. Effect of 12-week vitamin D supplementation on 25[OH]D status and performance in athletes with a spinal cord injury. Nutrients 2016; 8(10): 586.
Oleson CV , Patel PH, Wuermser LA. Influence of season, ethnicity, and chronicity on Vitamin D deficiency in traumatic spinal cord injury. J Spinal Cord Med 2010; 33(3): 202-13.
Robien K, Oppeneer SJ, Kelly JA et al. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract 2013; 28(2): 194- 208.
Koutrakis NE, Goldstein RL, Walia P. Vitamin D, diet, and lifestyle in a chronic SCI population. Spinal Cord 2019; 57(2): 117–27.
Brown R, DiMarco AF, Hoit JD et al. Respiratory Dysfunction and Management in Spinal Cord Injury. Respir Care 2006; 51(8): 853–70.
Jaakkola MS, Jaakkola JJ, Ernst P et al. Respiratory symptoms in young adults should not be overlooked. Am Rev Respir Dis 1993; 147(2): 359–66.
Vestbo J, Rasmussen FV. Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 1989; 2(8): 710–15.
Pfeffer PE, Hawrylowicz CM. Vitamin D and lung disease. Thorax 2012; 67(11): 1018-20.
Khoo AL, Chai L, Koenen H et al. Translating the role of vitamin D3 in infectious diseases. Crit Rev Microbiol 2012; 38(2): 122–35.
Hoyer-Hansen M, Nordbrandt SP, Jaattela M. Autophagy as a basis for the health-promoting effects of vitamin D. Trends Mol Med 2010; 16(7): 295–302.
Clark K, Goldstein RL, Hart JE, et al. Plasma vitamin D, past chest illness, and risk of future chest illness in chronic spinal cord injury (SCI): a longitudinal observational study. Spinal cord 2020; 58(4): 504-12
Garshick E, Walia P, Goldstein RL et al. Associations between vitamin D and pulmonary function in chronic spinal cord injury. J Spinal Cord Med 2019; 42(2): 171-77
Walia P, Goldstein RL, Teylan M et al. Associations between vitamin D, adiposity, and respiratory symptoms in chronic spinal cord injury. J Spinal Cord Med 2018; 41(6): 667-75.
Dauty M, Perrouin Verbe B, Maugars Y et al. Supralesional and sublesional bone mineral density in spinal cord-injured patients. Bone 2000; 27(2): 305–09.
Zehnder Y, Luthi M, Michel D et al. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury:a cross-sectional observational study in 100 paraplegic men. Osteoporos Int 2004; 15(3): 180-89
Roberts D, Lee W, Cuneo RC et al. Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endocrinol Metab 1998; 83(2): 415–22.
Bauman WA, Zhong Y-G, Schwartz E. Vitamin D deficiency in veterans with chronic spinal cord injury. Metabolism 1995; 44(12): 1612–16.
Karapolat I, Karapolat HU, KIrazlI Y et al. Longitudinal study of bone loss in chronic spinal cord injury patients. J Phys Ther Sci 2015; 27(5): 1429-33.
Vaziri ND, Pandiun MR, Segal JL et al. Vitamin D, Parathormone, and Calcitonin Profiles in Persons With Long-Standing Spinal Cord Injury. Arch Phys Med Rehabil 1994; 75(7): 766-69.
Morse LR , Nguyen N , Battaglino RA et al. Wheelchair use and Lipophilic Statin Medications May Influence Bone Loss in Chronic Spinal Cord Injury: Findings from the FRASCI-bone loss Study. Osteoporos Int 2016; 27(12): 3503-11.
Jørgensen V, Slettahjell HB, Roaldse KS et al. Carboxy terminal collagen crosslinks as a prognostic risk factor for fall-related fractures in individuals with established spinal cord injury. Spinal Cord 2019; 57(11): 985-91.
Bauman WA, Spungen AM, Morisson N et al. Effect of a vitamin D analog on leg bone mineral density in patients with chronic spinal cord injury. J Rehabil Res Rev 2005; 42(5): 625-34.
Girgis CM, Clifton-Bligh RJ, Turner N et al. Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin Endocrinol (Oxf) 2014; 80(2): 169-81
Girgis CM, Clifton-Bligh RJ, Mokbel N et al. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 2014; 155(2): 347–57
Ceglia L, da Silva Morais M, Park LK et al. Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle. J Mol Histol 2010; 41(2-3): 137-42
Wagatsuma A, Sakuma K. Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int 2014; 2014: 121254.
Girgis CM, Clifton-Bligh RJ, Mokbel N et al. Vitamin D signaling regulates proliferation, differentiation, and myotube size in C2C12 skeletal muscle cells. Endocrinology 2014; 155(2): 347-57.
Girgis CM, Clifton-Bligh RJ, Hamrick MW et al. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 2013; 34(1): 33–83.
Barbonetti A, D’Andrea S, Martorella A et al. Low vitamin D levels are independent predictors of 1-year worsening in physical function in people with chronic spinal cord injury: a longitudinal study. Spinal Cord 2018; 56(5): 494-01.
Barbonetti A, Sperandio A, Micillo A et al. Independent Association of Vitamin D with Physical Function in People with Chronic Spinal Cord Injury. Arch Phys Med Rehabil 2016; 97(5): 726-32.
Wong KE, Szeto FL, Zhang W et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol 2009; 296(4): 820-28.
Reid IR. Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging 2004; 21(1): 7 –17
McCarty DE, Chesson AL Jr, Jain SK et al. The link between vitamin D metabolism and sleep medicine. Sleep Med Rev 2014; 18(4): 311-19
Taniguchi A, Kataoka K, Kono T et al. Parathyroid hormone-induced lipolysis in human adipose tissue. J Lipid Res 1987; 28(5): 490 –94.
Beal C, Gorgey A, Moore P. Higher dietary intake of vitamin D may influence total cholesterol and carbohydrate profile independent of body composition in men with Chronic Spinal Cord Injury. J Spinal Cord Med 2018; 41(4): 459-70.
C, Béraud-Dufour S, Devader C et al. Potentiation of Calcium Influx and Insulin Secretion in Pancreatic Beta Cell by the Specific TREK-1 Blocker Spadin. J Diabetes Res 2016; 2016: 3142175.
Bland R, Markovic D, Hills CE et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004;89-90(1-5):121-25.
Lee S, Clark SA, Gill RK et al. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134(4): 1602-10
Maestro B, Campion J, Davila N et al. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000 ;47(4): 383-91
Weaver FM, Collins EG, Kurichi J et al. Prevalence of obesity and high blood pressure in veterans with spinal cord injuries and disorders: a retrospective review. Am J Phys Med Rehabil 2007; 86(1): 22-29.
Jones LM, Legge M, Goulding A. Healthy body mass index values often underestimate body fat in men with spinal cord injury. Arch Phys Med Rehabil 2003; 84(7): 1068–71.
Gorgey AS, Dolbow DR, Dolbow JD et al. Effects of spinal cord injury on body composition and metabolic profile – Part I. J Spinal Cord Med 2014; 37(4): 693–02.
Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72(3): 690-93.
Ajabshir S, Asif A, Nayer A. The effects of vitamin D on the rennin-angiotensin system. J Nephropathol 2014; 3(2): 41-43.
Pilz S, Tomaschitz A, Ritz E et al. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009; 6(10): 621-30.
Dong J, Wong SL, Lau CW et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J 2012; 33(23): 2980–90.
Sakellariou VI, Grigoriou E, Mavrogenis AF et al. Heterotopic ossification following traumatic brain injury and spinal cord injury: An insight into the etiology and pathophysiology. J Musculoskelet Neuronal Interact 2012; 12(4): 230 –40
van Kuijk AA, Geurts AC, van Kuppevelt HJ. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 2002; 40(7): 313-26.
Ish-Shalom S, Segal E, Salganik T et al. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008; 93(9): 3430-35.
Heaney RP, Recker RR, Grote J et al. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011; 96(3): E447–52.
Holick MF, Biancuzzo RM, Chen TC et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93(3): 677-81.
Bauman WA, Emmons RR, Cirnigliaro CM et al. An effective oral vitamin D replacement therapy in persons with spinal cord injury. J Spinal Cord Med 2011; 34( 5): 455-60.
Bauman WA, Morrison NG, Spungen AM. Vitamin D Replacement Therapy In Persons With Spinal Cord Injury. J Spinal Cord Med 2005; 28(3): 203-07.
